About Esco Aster

Esco Aster is a vertically-integrated contract research (CRO), contract development and manufacturing organization (CDMO) founded and deeply rooted by scientists enabling fellow scientists to translate their benchwork into life-saving diagnostics, medicines, therapies, cosmeceuticals, and cellular agriculture, at affordable prices for self-sufficiency of the country.

We make complex manufacturing simple via our proprietary best-in-class continuous manufacturing platforms providing a reliable and linearly scalable outcome with a track record of being used in 7 commercial human and animal health vaccines.

We continuously invest in meeting unmet clinical needs by unlocking manufacturing bottlenecks for current and new platform modalities.

Together, we are working on an interconnected one health approach to bring your next molecule into the clinic and life.

Join us for the world we are making redefining food and medicine for the current and future generations to come.

Esco Aster.
One World. One Health.

About Us

about esco vid

Esco Aster spun off in 2018 as an independent wholly owned subsidiary of Esco Lifesciences Group. Esco Lifesciences Group is founded in Singapore and is the global group and corporate headquarters since 1978.

> 1,300 employees globally

42 locations

more than 20 countries

8 manufacturing sites and R&D centers

EXPLORE

Our Offerings

Esco Aster provides variety of products and services based on best-in-class manufacturing platforms with focus on new modalities.

We aim to provide the highest yield lowest cost with linearly scalable quality to better promote healthcare access especially in the developing world, lower middle income countries.

Manufacturing Platforms

Our Adherent Cell Tide Motion® Platform forms the core of our process development (PD) / Clinical Trial Material (CTM) which is translational bridge to accelerate clinical/investigational medicinal products from bench to good laboratory practice (GLP), Phase 1 / 2 clinical trial material, intermediates and Phase 3 bridging studies when converting from roller bottles, microcarriers or multilayer 2D planar cultureware into Adherent Cell Tide Motion® Platform which is linearly scalable to commercial scale.

Learn more about our COGS targets from our different manufacturing platforms!

EXPLORE
Pharmaceuticals and Biotechnology
Speciality Diagnostics
Biosciences & Tools
Cell and Gene Therapy
Speciality API's / Linkers
Modular Design & Build, Validation

Our Products

Esco Aster is one of the earliest responders to Singapore COVID-19 self sufficiency across Diagnostics, Therapeutics and Vaccines.

See more on our dedicated COVID-19 page for our end to end trace, test and treat platforms. We are providing a variety of biopharma, bioscience to cell lines, drug substances and drug products as well.

COVID-19 Products

COVID-19 Products

In view of the current pandemic situation, Esco Aster is working together with its collaborators to develop a diagnostic and therapeutic platform against COVID-19. Also, Esco Aster espouses a Trace, Test, and Treat at decentralized community, ports and border level for our end-to-end level to actively diagnose and isolate to prevent community spread. Through these means, we have developed an end-to-end platform to diagnose and treat the disease.
Bioscience Tools

Bioscience Tools

We provide bioprocessing tools, focusing on adherent cell culture, to make human lives healthier and safer.
Biopharmaceutical Tools

Biopharmaceutical Tools

We provide specialist services, equipment packages, and process solutions from our core platform products. This leads to improved operator protection, reduction of cross contamination, and a more efficient biopharmaceutical processing.
Nasal Spray (COVID-19) Vaccine

Nasal Spray (COVID-19) Vaccine

We are simultaneously working on with various collaborators to advance the development and commercial-scale production of therapeutics and vaccines using our proprietary Adherent Tide Motion® technology.
Active Pharmaceutical Ingredients (APIs)

Active Pharmaceutical Ingredients (APIs)

We have the expertise for developing a robust and scalable process using continuous flow chemistry as well as modified batch process methods to combat the increasing complexity in API synthesis.
Cell Lines

Cell Lines

We work with you to provide cGMP compliant, high-producing, and stable cell lines for your protein of interest with desired post translational modifications (PTMs).

Our Locations

Esco Aster operates on dedicated sites based on our applications of our manufacturing platforms, each site has dedicated scientists working on specific modalities. Esco Aster will continue to scale up with our collaborators and partners for future commercial expansion in Singapore or as Internal Tech Transfer to client choice of country. Facilities and applications are:

Esco AsterTide PD-Phase 2 CTM (Cells/Viruses/EVs)

#02-04 Blk 67 Ayer Rajah Crescent Singapore 139950

Esco AsterMavors Cellular Agriculture and Alternative Proteins (Food)

#03-20 Blk 71 Ayer Rajah Crescent Singapore 139951

Esco Aster Fermentation (Plasmids)

21 Changi South Street 1 Singapore 486777

esco map
Esco Aster COE China
Esco Aster COE India
• Esco Aster Singapore Manufacturing
• Esco Aster PD/Intermediates/Clinical Trial Material Operations
Esco Aster COE USA

Our Pipeline

See where we are at in our product development pipeline! These consist of our internal and international co-development collaborations with specific focus on vaccines, cell therapy, new modalities for oncology, rare/orphan drugs, genetic diseases.

See our different modes of How We Work.

Explore

Newsletter Sign Up